title: The influence of interpreters' professional background and experience on the interpretation of multimodality imaging of pulmonary lesions using 18F-3'-deoxy-fluorothymidine and 18F-fluorodeoxyglucose PET/CT.
abstract: OBJECTIVE
  Based on the results of a recently accomplished multicenter clinical trial for the incremental value of a dual-tracer (18F-FDG and 18F-FLT), dual-modality (PET and CT) imaging in the differential diagnosis of pulmonary lesions, we investigate some issues that might affect the image interpretation and result reporting.
  
  
  METHODS
  The images were read in two separate sessions. Firstly the images were read and reported by physician(s) of the imaging center on completion of each PET/CT scanning. By the end of MCCT, all images collected during the trial were re-read by a collective of readers in an isolated, blinded, and independent way.
  
  
  RESULTS
  One hundred sixty two patients successfully passed the data verification and entered into the final analysis. The primary reporting result showed adding 18F-FDG image information did not change the clinical performance much in sensitivity, specifity and accuracy, but the ratio between SUVFLT and SUVFDG did help the differentiation efficacy among the three subgroups of patients. The collective reviewing result showed the diagnostic achievement varied with reading strategies. ANOVA indicated significant differences among (18)F-FDG, (18)F-FLT in SUV (F = 14.239, p = 0.004). CT had almost the same diagnostic performance as 18F-FLT. When the 18F-FDG, 18F-FLT and CT images read in pair, both diagnostic sensitivity and specificity improved. The best diagnostic figures were obtained in full-modality strategy, when dual-tracer PET worked in combination with CT.
  
  
  CONCLUSIONS
  With certain experience and training both radiologists and nuclear physicians are qualified to read and to achieve the similar diagnostic accuracy in PET/CT study. Making full use of modality combination and selecting right criteria seems more practical than professional back ground and personal experience in the new hybrid imaging technology, at least when novel tracer or application is concerned.
authors.affiliation: Department of Nuclear Medicine, Chinese PLA General Hospital, Beijing, People's Republic of China.
authors.forename: Bai-xuan
authors.initials: BX
authors.lastname: Xu
authors.forename: Chang-bin
authors.initials: CB
authors.lastname: Liu
authors.forename: Rui-min
authors.initials: RM
authors.lastname: Wang
authors.forename: Ming-zhe
authors.initials: MZ
authors.lastname: Shao
authors.forename: Li-ping
authors.initials: LP
authors.lastname: Fu
authors.forename: Yun-gang
authors.initials: YG
authors.lastname: Li
authors.forename: Jia-he
authors.initials: JH
authors.lastname: Tian
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002983:Clinical Competence; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008171:Lung Diseases / Q000175:diagnosis*; D008297:Male; D008875:Middle Aged; D064847:Multimodal Imaging; D049268:Positron-Emission Tomography; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D014057:Tomography, X-Ray Computed
chemical_list: D019788:Fluorodeoxyglucose F18
references.citation: J Nucl Med. 2008 Feb;49(2):186-94
references.pmid: 18199618
references.citation: J Nucl Med. 2007 Jun;48(6):855-6
references.pmid: 17536105
references.citation: J Nucl Med. 2006 Aug;47(8):13N-15N, 17N-21N, 22N-26N passim
references.pmid: 16929575
references.citation: J Nucl Med. 2005 Aug;46(8):1249-51
references.pmid: 16085577
references.citation: J Nucl Med. 2007 Apr;48(4):547-52
references.pmid: 17401090
references.citation: J Nucl Med. 2006 Mar;47(3):443-50
references.pmid: 16513614
references.citation: Eur Radiol. 2004 Jun;14(6):1025-33
references.pmid: 14872280
references.citation: J Nucl Med. 2007 Aug;48(8):1237-44
references.pmid: 17631549
references.citation: J Nucl Med. 2007 Mar;48(3):445-54
references.pmid: 17332623
references.citation: J Clin Oncol. 2006 May 1;24(13):2098-104
references.pmid: 16648512
references.citation: Semin Nucl Med. 2006 Apr;36(2):157-68
references.pmid: 16517237
references.citation: J Nucl Med. 2007 Feb;48(2):214-20
references.pmid: 17268017
references.citation: Int J Oncol. 2003 Feb;22(2):253-67
references.pmid: 12527920
references.citation: J Clin Oncol. 2006 Jun 20;24(18):2793-9
references.pmid: 16682724
references.citation: J Nucl Med. 2005 Aug;46(8):1352-5
references.pmid: 16085594